Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines
- PMID: 10909420
Gene therapy for T cell-mediated autoimmunity: teaching the immune system how to restrain its own harmful activities by targeted DNA vaccines
Abstract
We recently used a modification of gene therapy (naked DNA vaccination) to induce immunological memory against self-pro-inflammatory chemokines such as macrophage inflammatory protein-1 alpha or monocyte chemoattractant protein-1, and against the pro-inflammatory cytokine tumor necrosis factor-alpha. First, DNA constructs encoding each of the different pro-inflammatory mediators together with a repeated immunostimulatory sequence were prepared. Then, experiment animals were subjected to a repeated administration of each construct. Under these conditions, tolerance to the product of each insert was broken, and immunological memory established. Upon induction of experimental autoimmune encephalomyelitis, a T cell-mediated autoimmune disease of the central nervous system that serves as a model for multiple sclerosis or adjuvant induced arthritis, this memory was "turned on" to provide DNA-vaccinated animals a high state of disease resistance. Antibodies to the product of each inserted gene were isolated form these animals. Each antibody was found capable of neutralizing in vitro the chemoattractive properties of each relevant chemokine, thereby transferring disease resistance. Interestingly, the level of their production was dependent on disease severity, that is, each titer was accelerated in accordance with disease progression. Thus, by using a simple gene therapy technique the immune system could be "re-educated" to restrain its own harmful activities.
Similar articles
-
Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines.Curr Opin Mol Ther. 2004 Feb;6(1):27-33. Curr Opin Mol Ther. 2004. PMID: 15011778 Review.
-
Augmentation of natural immunity to a pro-inflammatory cytokine (TNF-alpha) by targeted DNA vaccine confers long-lasting resistance to experimental autoimmune encephalomyelitis.Gene Ther. 1999 Jun;6(6):1128-38. doi: 10.1038/sj.gt.3300915. Gene Ther. 1999. PMID: 10455416
-
An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.J Immunol. 1995 Nov 15;155(10):5003-10. J Immunol. 1995. PMID: 7594507
-
Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines.J Autoimmun. 1999 Aug;13(1):21-9. doi: 10.1006/jaut.1999.0306. J Autoimmun. 1999. PMID: 10441164
-
Protection from autoimmunity by DNA vaccination against T-cell receptor.Methods Mol Med. 2006;127:269-80. doi: 10.1385/1-59745-168-1:269. Methods Mol Med. 2006. PMID: 16988460 Review.
Cited by
-
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene.Eur J Immunol. 2003 Dec;33(12):3232-41. doi: 10.1002/eji.200324000. Eur J Immunol. 2003. PMID: 14635031 Free PMC article.
-
Recruitment and expansion of dendritic cells in vivo potentiate the immunogenicity of plasmid DNA vaccines.J Clin Invest. 2004 Nov;114(9):1334-42. doi: 10.1172/JCI22608. J Clin Invest. 2004. PMID: 15520866 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials